Physician profile
Eric D Medina
NPI 1407269301
$8,304.88
in general payments reported to CMS, 2019-2025
24 companies · $1,157 in 2025
The $1,157 reported for 2025 was more than what 80% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $978 · 2020: $235 · 2021: $313 · 2022: $390 · 2023: $2,376 · 2024: $2,855 · 2025: $1,157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,531 · Travel and Lodging: $2,858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,530.64 |
| Travel and Lodging | $2,857.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $4,449.92 | 2019-2025 | Lensx, Clareon, Centurion |
| Abbvie INC. | $965.37 | 2022-2025 | |
| Sight Sciences, INC. | $454.48 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Bausch & Lomb Americas INC. | $347.37 | 2024-2025 | Miebo, Xiidra |
| Allergan, INC. | $274.05 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $244.63 | 2019-2021 | |
| Glaukos Corporation | $208.82 | 2023 | Radius Xr |
| Dompe US, INC. | $197.07 | 2024-2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $191.94 | 2022-2025 | Tecnis Iol, Tecnis Iol |
| Horizon Therapeutics Plc | $160.33 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $147.49 | 2019 | |
| Omeros Corporation | $140.27 | 2019 | |
| Novartis Pharmaceuticals Corporation | $83.08 | 2019-2022 | |
| Biotissue Holdings INC. | $68.60 | 2024 | |
| Kala Pharmaceuticals, INC. | $65.87 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $58.95 | 2025 | Acthar |
| Lkc Technologies, INC. | $56.79 | 2025 | |
| Harrow Eye, LLC | $37.78 | 2025 | Vevye |
| Apellis Pharmaceuticals, INC. | $36.62 | 2024 | Syfovre |
| Tarsus Pharmaceuticals, INC. | $35.02 | 2024 | Xdemvy |
| Rxsight INC | $25.14 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Sun Pharmaceutical Industries INC. | $24.34 | 2019 | |
| Amgen INC. | $18.32 | 2025 | Tepezza |
| Oyster Point Pharma, INC. | $12.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Medina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.